NO20043397L - Prucaloprid-N-oksid - Google Patents

Prucaloprid-N-oksid

Info

Publication number
NO20043397L
NO20043397L NO20043397A NO20043397A NO20043397L NO 20043397 L NO20043397 L NO 20043397L NO 20043397 A NO20043397 A NO 20043397A NO 20043397 A NO20043397 A NO 20043397A NO 20043397 L NO20043397 L NO 20043397L
Authority
NO
Norway
Prior art keywords
prucalopride
oxide
compositions
novel
concerned
Prior art date
Application number
NO20043397A
Other languages
English (en)
Other versions
NO326580B1 (no
Inventor
Willy Joannes Carolu Laerhoven
Joannes Adrianus Jac Schuurkes
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20043397L publication Critical patent/NO20043397L/no
Publication of NO326580B1 publication Critical patent/NO326580B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20043397A 2002-01-16 2004-08-16 Prucaloprid-N-oksid NO326580B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075157 2002-01-16
PCT/EP2003/000276 WO2003059906A1 (en) 2002-01-16 2003-01-13 Prucalopride-n-oxide

Publications (2)

Publication Number Publication Date
NO20043397L true NO20043397L (no) 2004-08-16
NO326580B1 NO326580B1 (no) 2009-01-12

Family

ID=8185531

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043397A NO326580B1 (no) 2002-01-16 2004-08-16 Prucaloprid-N-oksid

Country Status (18)

Country Link
US (2) US20050085510A1 (no)
EP (1) EP1467991B1 (no)
JP (1) JP2005514458A (no)
KR (1) KR101023433B1 (no)
CN (1) CN1330646C (no)
AT (1) ATE295845T1 (no)
AU (1) AU2003206722B2 (no)
CA (1) CA2471729C (no)
DE (1) DE60300683T2 (no)
ES (1) ES2242940T3 (no)
IL (1) IL163025A (no)
MX (1) MXPA04006888A (no)
NO (1) NO326580B1 (no)
NZ (1) NZ533041A (no)
PL (1) PL214274B1 (no)
RU (1) RU2301806C2 (no)
WO (1) WO2003059906A1 (no)
ZA (1) ZA200405654B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE417834T1 (de) * 2005-08-22 2009-01-15 Solvay Pharm Bv N-oxide als prodrugs von piperazin- und piperidinderivaten
AR058022A1 (es) * 2005-08-22 2008-01-23 Solvay Pharm Bv Derivados de benzooxazoles, composiciones farmaceuticas y su uso para el tratamiento de desordenes del sistema nervioso.
US7750013B2 (en) 2005-08-22 2010-07-06 Solvay Pharmaceuticals, B.V. N-oxides as prodrugs of piperazine and piperidine derivatives
US20070294778A1 (en) * 2006-03-16 2007-12-20 Adam Rich Zebrafish model for assessing gastrointestinal motility
WO2017137910A1 (en) 2016-02-11 2017-08-17 Symed Labs Limited Processes for the preparation of highly pure prucalopride succinate and its intermediates
CN112500398A (zh) * 2020-12-24 2021-03-16 艾希尔（深圳）药物研发有限公司 一种普鲁卡必利氧化物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716587D0 (en) * 1987-07-14 1987-08-19 Shell Int Research Preparing thiophene derivatives
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JP3953097B2 (ja) * 1994-09-27 2007-08-01 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｎ−置換ピペリジニル二環式ベンゾエート誘導体
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
TW382017B (en) * 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
NZ330263A (en) * 1996-02-15 1999-06-29 Janssen Pharmaceutica Nv Esters of 3-hydroxy-piperidinemethanol derivatives to improve gastric emptying
TW445263B (en) * 1996-02-29 2001-07-11 Janssen Pharmaceutica Nv Novel esters of 1,4-disubstituted piperidine derivatives
KR20010080025A (ko) * 1998-11-23 2001-08-22 디르크 반테 소화불량 치료용 의약의 제조를 위한 프루칼로프라이드의용도
TW592709B (en) * 1999-04-29 2004-06-21 Janssen Pharmaceutica Nv Prucalopride oral solution

Also Published As

Publication number Publication date
KR20040074981A (ko) 2004-08-26
US8063069B2 (en) 2011-11-22
ES2242940T3 (es) 2005-11-16
PL370379A1 (pl) 2005-05-16
NO326580B1 (no) 2009-01-12
US20080125464A1 (en) 2008-05-29
CN1615308A (zh) 2005-05-11
DE60300683D1 (de) 2005-06-23
MXPA04006888A (es) 2004-12-06
HK1075894A1 (zh) 2005-12-30
NZ533041A (en) 2006-04-28
EP1467991B1 (en) 2005-05-18
CA2471729C (en) 2010-03-23
CA2471729A1 (en) 2003-07-24
AU2003206722A1 (en) 2003-07-30
JP2005514458A (ja) 2005-05-19
RU2301806C2 (ru) 2007-06-27
WO2003059906A1 (en) 2003-07-24
US20050085510A1 (en) 2005-04-21
CN1330646C (zh) 2007-08-08
KR101023433B1 (ko) 2011-03-25
DE60300683T2 (de) 2006-04-27
PL214274B1 (pl) 2013-07-31
AU2003206722B2 (en) 2008-01-24
ATE295845T1 (de) 2005-06-15
RU2004124844A (ru) 2006-01-20
IL163025A (en) 2010-06-16
ZA200405654B (en) 2005-09-28
EP1467991A1 (en) 2004-10-20

Similar Documents

Publication Publication Date Title
BRPI0412999A (pt) 2-aminotetralina substituìda para tratamento de depressão
CA2472954A1 (en) Aza-arylpiperazines
NO20090328L (no) Nye forbindelser 385
BR0008979A (pt) Composto quìmico, uso de um composto, método de tratamento, processo de preparação de um composto, composição farmacêutica e método de fabricação da mesma
SE0104341D0 (sv) New use
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
EA200401114A3 (ru) Замещённые гидроксиэтиламины
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
IS2517B (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
SE0102440D0 (sv) New compound
MXPA05010020A (es) Derivados de oxamida.
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
WO2004041802A8 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
SE0401655D0 (sv) New compounds
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
GB0212410D0 (en) Organic compounds
ATE295845T1 (de) Prucaloprid-n-oxid
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
ATE325809T1 (de) Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure
ATE466007T1 (de) 5-substituierte indol-2-carbonsäureamidderivate
HRP20050831A2 (en) Novel oxazole derivatives, their manufacture and use as pharmaceutical agents

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA PHAMACEUTICAL COMPANY LIMITED, JP

MK1K Patent expired